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Background The deep inferior epigastric artery perforator (DIEP) flap is the commonest flap 
used for breast reconstruction after mastectomy. It is performed as a unilateral (based on one 
[unipedicled] or two [bipedicled] vascular pedicles) or bilateral procedure following unilateral 
or bilateral mastectomies. No previous studies have comprehensively analyzed analgesia re-
quirements and hospital stay of these three forms of surgical reconstruction.
Methods A 7-year retrospective cohort study (2008–2015) of a single-surgeon’s DIEP-pa-
tients was conducted. Patient-reported pain scores, patient-controlled morphine require-
ments and recovery times were compared using non-parametric statistics and multivariable 
regression.
Results The study included 135 participants: unilateral unipedicled (n=84), unilateral bipedi-
cled (n=24) and bilateral unipedicled (n=27). Univariate comparison of the three DIEP types 
showed a significant difference in 12-hour postoperative morphine requirements (P=0.020); 
bipedicled unilateral patients used significantly less morphine than unipedicled (unilateral) 
patients at 12 (P=0.005), 24 (P=0.020), and 48 (P=0.046) hours. Multivariable regression 
comparing these two groups revealed that both reconstruction type and smoking status were 
significant predictors for 12-hour postoperative morphine usage (P=0.038 and P=0.049, re-
spectively), but only smoking, remained significant at 24 (P=0.010) and 48 (P=0.010) hours. 
Bilateral reconstruction patients’ mean hospital stay was 2 days longer than either unilateral 
reconstruction (P<0.001).
Conclusions Although all three forms of DIEP flap breast reconstruction had similar postop-
erative pain measures, a novel finding of our study was that bipedicled DIEP flap harvest 
might be associated with lower early postoperative morphine requirements. Bilateral and bi-
pedicled procedures in appropriate patients might therefore be undertaken without signifi-
cantly increased pain/morbidity compared to unilateral unipedicled reconstructions. 
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INTRODUCTION
Post-mastectomy breast reconstruction can be undertaken us-
ing implants, the patient’s own tissues or a combination. The 
advantages of using autologous tissue include superior cosmesis 
and avoidance of implant-related complications [1]. The com-
monest autologous donor site is the lower abdomen which 
yields ample amounts of well vascularized tissue which is often 
harvested as a perforator flap namely the deep inferior epigastric 
artery perforator (DIEP) [2,3]. Perforator flaps have reduced 
donor site morbidity and postoperative analgesic requirements 
with improved patient satisfaction compared to muscle-contain-
ing flaps such as the transverse rectus abdominis myocutaneous 
(TRAM) flaps [2]. DIEP flaps are hence considered the gold 
standard for autologous breast reconstruction [3]. DIEP flap 
breast reconstruction can be performed as a unilateral or bilater-
al procedure following unilateral or bilateral mastectomies. The 
unilateral flap can be harvested based on one (unipedicled) or 
two (bipedicled) vascular pedicles. The bipedicled flap entails 
vessel dissection through the substance and sheath of the rectus 
muscles on both sides of the lower abdomen akin to the harvest 
of two separate flaps (bilateral breast reconstruction) but is then 
used for the reconstruction of one rather two breasts (unilateral 
bipedicled category). Reduced postoperative pain is correlated 
with decreased complications, accelerated discharge from hos-
pital, and improved patient experience [4]. There have hitherto 
been no detailed direct comparisons of early postoperative re-
covery based on solely DIEP flap procedure type. 
The aim of the study therefore was to compare postoperative 
pain and early recovery for bilateral unipedicled, unilateral uni-
pedicled and unilateral bipedicled DIEP flap breast reconstruc-
tions to determine if there was a difference in the early morbidi-
ty associated with these procedure subtypes. It was hypothe-
sized that since bilateral procedures and bipedicled procedures 
are more invasive they could lead to increased pain, morbidity 
and hospital stay. 
METHODS
A 7-year retrospective cohort study (2008–2015) of consecu-
tive patients (n = 178) was conducted at a single tertiary referral 
center. All patients underwent post-mastectomy DIEP free flap 
breast reconstruction by one surgeon (CMM). They were iden-
tified from a prospectively collected free flap database and the 
surgeon’s free flap logbook. This cohort was then divided into 
three groups based on type of DIEP breast reconstruction; all 
were anastomosed to the internal mammary vessels exposed via 
the total rib preservation technique. Patients were classified ac-
cording to whether they had unilateral breast reconstruction 
with either a single vascular pedicle (unilateral unipedicled) or a 
double pedicle (unilateral bipedicled) or a bilateral breast recon-
struction using hemi-DIEP flaps based on a single pedicle (bi-
lateral unipedicled).
Data were extracted from the patient’s electronic and paper 
medical records. Postoperative analgesia was provided using the 
senior author’s standardized protocol: morphine-based intrave-
nous (IV) patient-controlled analgesia (PCA) device, regular 
maximum dose IV paracetamol and supplemented (rarely and 
recorded) with oral morphine alone. The data collected includ-
ed: the patient’s age, weight, body mass index (BMI), the dura-
tion of PCA use, time to catheter removal (as a proxy for time to 
ambulation), length of hospital stay, total morphine use at 12, 24 
and 48 hours postoperatively (both total and per kilogram body 
weight), self-reported pain scores sampled every 4 hours until the 
PCA was taken down, maximum pain scores and pain score on 
discharge. Pain scores were reported on the 11-point numerical 
rating scale (NRS). Additional oral morphine was converted to 
the equivalent dose in terms of the IV PCA (at a ratio of 2:1) [5].
This study was part of a quality improvement assessment and 
an ongoing departmental free flap audit within the university 
hospital. Quality improvement and audit assessments are part 
of a larger framework for clinical governance. Clinical gover-
nance is compulsory within the UK National Health Service 
(NHS), therefore no specific ethical committee approval was 
needed, and individual patient consent for their anonymized 
retrospective data was not required to conduct or publish this 
study.
Patients who underwent superficial inferior epigastric artery 
perforator (n = 6) or free TRAM (n = 1) flap harvest, did not 
have rib-preserving DIEP reconstructive surgery (n = 1), or had 
insufficient medical information (n = 35) were excluded from 
the study (Fig. 1). 
Continuous and approximately normal data such as age, weight 
and BMI were compared across the three procedure types using 
an analysis of variance test. Discrete (categorical) data such as 
smoking status, diabetic comorbidity, incidence of nausea and 
vomiting, prior chemotherapy and prior radiotherapy were 
compared using chi-square tests. The postoperative pain scores, 
total morphine doses used, time to PCA discontinuation, post-
operative catheter removal and length of hospital stay were non-
normal and compared non-parametrically across the three pro-
cedure types using Kruskal Wallis tests. Multivariable linear re-
gression used the REG regression application on SAS (vide in-
fra) supposing independent effects. Total morphine doses and 
total doses per kilogram across two procedure types were com-
pared using Mann Whitney U tests. 
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Any patients given fentanyl as the opioid in their PCA regimen 
or if their morphine doses were uncertain (n = 36) were exclud-
ed from the comparisons of morphine. Data were stored on an 
excel spreadsheet and all statistical analyses were conducted on 
specific statistical software: SAS (Statistical Analysis System) re-
lease 3.71, University Edition 2.7 9.4 M5 (“SAS”). All statistical 
tests were two-sided and α = 0.05 was deemed significant. 
RESULTS
Demographics 
The study sample (n = 135 patients) was categorized into three 
DIEP groups: unilateral unipedicled (n = 84), unilateral bipedi-
cled (n = 24) and bilateral unipedicled (n = 27) reconstructions 
(referred to as unipedicled, bipedicled and bilateral reconstruc-
tions respectively). The mean age of the cohort was 47.3 years 
and it was significantly different across the three groups 
(P = 0.002). The bilateral group patients were younger (42.9 
years) than those in the bipedicled (45 years) and unipedicled 
(49.5 years) groups. Patients undergoing bipedicled flap recon-
struction of a single breast were also significantly younger than 
those undergoing unipedicled surgery (P = 0.039). The mean 
BMI of the cohort was 28.5 kg/m2 and it was significantly dif-
ferent across the three groups (P < 0.001). The bipedicled 
group had a lower BMI (24.7 kg/m2) compared to bilateral pa-
tients (30.3 kg/m2) and unipedicled patients (29.1 kg/m2) (Ta-
ble 1). The UK mean for women is 27.0 kg/m2 [6]. 
Morphine use: across all three groups
The mean total morphine used by 12 hours postoperatively in 
the various procedure types was significantly different (P =  
0.020, Kruskal Wallis test) being 17.2 mg, 19.7 mg, and 8.9 mg 
for the bilateral, unilateral unipedicled and unilateral bipedicled 
groups respectively (Table 2). There was, however, no statistical 
difference in total morphine use at 24 and 48 hours.
The total morphine dose at 12 hours postoperatively was then 
analyzed by multivariable linear regression including the vari-
ables of reconstruction type, patient age, BMI, reconstruction 
A flow diagram describing the patients included and excluded from the final study cohort. DIEP, deep inferior epigastric artery perforator. 
Fig. 1. A flow diagram 
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timing, smoking status, diabetic disease, prior chemotherapy 
and radiotherapy. The regression analysis showed that of these, 
only procedure type was associated with a statistically signifi-
cant difference in morphine requirements (P = 0.036).
Morphine use: pairwise comparisons
The previous section described that there was a difference in 
morphine use at the 12-hour timepoint across all three groups 
and, although the mean total use at the 12-hour time point was 
most different between unipedicled (19.7 mg) and bipedicled 
(8.9 mg) unilateral groups, it did not reveal that the difference 
between the three was due to a significant difference between 
any two particular groups. To find out why there was a signifi-
cant difference between the three operative groups, pairwise 
comparisons (i.e., unilateral bipedicled vs. unilateral unipedi-
cled, unilateral bipedicled vs. bilateral, unilateral unipedicled vs. 
bilateral) of the postoperative morphine requirements at 12, 24, 
and 48 hours were performed (Mann Whitney U tests). The 
only statistically significant differences were found when com-
paring the unilateral unipedicled and unilateral bipedicled re-
constructions, and not just at the 12-hour time point which is 
what was seen in the comparison across the three groups. Pa-
tients undergoing bipedicled reconstructions consistently re-
quired a significantly lower total morphine dose than unipedi-
cled reconstructions at 12, 24, and 48 hours postoperatively 
(Table 3). After 12 hours, the total morphine requirements for 
bipedicled and unipedicled reconstructions were 8.9 mg and 
19.7 mg respectively (P = 0.005), after 24 hours were 18.8 mg 
and 35.5 mg respectively (P = 0.020), and after 48 hours were 
30.3 mg and 53.2 mg respectively (P = 0.046). These differences 
are clinically significant as the morphine use in bipedicled 
DIEPs was almost half than required by patients undergoing 
unilateral unipedicled procedures. 
Morphine use: multivariable analysis on the 
unipedicled and bipedicled comparison
A multivariable linear regression was performed to compare the 
bipedicled and unipedicled total morphine requirements at the 
12-, 24-, and 48-hour timepoints postoperatively (Table 4). 
This showed that the total morphine doses at 12 hours postop-
Characteristic
Bilateral 
reconstruction 
(n=27)
Bipedicled, unilateral 
reconstruction 
(n=24)
Unipedicled, unilateral 
reconstruction 
(n=84)
P-valuea)
Age at operation (yr) 42.9±8.7 45.0±7.0 49.5±9.4 0.002b)
Weight (kg) 85.3±13.1 65.7±7.5 77.5±12.2 <0.001b)
BMI (kg/m2) 30.3±3.6 24.7±3.7 29.1±4.3 <0.001b)
Timing of reconstruction <0.001
   Combination 6 (22.2) 0 0
   Delayed 0 3 (12.5) 21 (25.0)
   Immediate 21 (77.8) 21 (87.5)  62 (73.8)
   Salvage 0 0 1 (1.2)
Smoking status 0.29
   Non-smoker 25 (92.6) 23 (95.8) 77 (92.7)
   Smoker 1 (3.7) 0 7 (8.3)
   Not available 1 (3.7) 1 (4.1) 0
Diabetic comorbidity 0.55
   Non-diabetic 26 (96.3) 23 (95.8) 81 (96.4)
   Diabetic 0 0 2 (2.4)
   Not available 1 (3.7) 1 (4.1) 1 (1.19)
Chemotherapy 0.71
   No chemotherapy 6 (22.2) 4 (16.7) 20 (23.8)
   Experienced chemotherapy 21 (77.8) 20 (83.3) 61 (72.6)
   Not available 0 0 3 (3.6)
Radiotherapy 0.8
   No radiotherapy 9 (33.3) 8 (33.3) 31 (36.9)
   Experienced radiotherapy 18 (66.7) 15 (62.5) 47 (55.9)
   Not available 0 1 (4.1) 6 (7.1)
Values are presented as mean±SD or number (%).
DIEP, deep inferior epigastric artery perforator; BMI, body mass index.
a)Chi-square; b)Analysis of variance. Statistically significant, P<0.05.
Table 1. The characteristics of the study participants are described and compared statistically across the three types of DIEP 
reconstruction (n=135)
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eratively were still significantly lower for bipedicled reconstruc-
tions than unipedicled (P = 0.038). Additionally, non-smokers 
used significantly less morphine (P = 0.049) than smokers. 
However, at 24 hours, being a non-smoker was the only signifi-
cantly different variable (P = 0.01); the procedure type was no 
longer significant (P = 0.11). At 48 hours, additional factors 
were significant for reduced morphine usage: being a non-
smoker (P = 0.01), younger (P = 0.013) and a recipient of neo-
adjuvant chemotherapy (P = 0.03). As at 24 hours the type of 
reconstruction was no longer a significant factor (P = 0.18). 
Characteristic
Bilateral 
reconstruction 
(n=27)
Bipedicled, unilateral 
reconstruction 
(n=24)
Unipedicled, unilateral 
reconstruction 
(n=84)
P-valuea)
Time after surgery when PCA discontinued (hr) 50.8 (42.1–59.5) 50.5 (39.1–61.9) 49.8 (45.3–54.3) 0.93
Postoperative catheter removal (hr) 85.3 (75.9–94.8) 95.8 (76.3–115.2) 83.1 (78.6–87.6) 0.26
Length of hospital stay (day) 10.2 (9.1–11.3) 7.8 (7–8.5) 7.7 (7.2–8.3) <0.001
Total morphine use
   After 12 hr (mg) 17.2 (10.1–24.2) 8.9 (4.9–13.0) 19.7 (15.7–23.6) 0.02
   After 12 hr per kg (mg/kg)  0.20 (0.13–0.29) 0.15 (0.08–0.21) 0.25 (0.20–0.30) 0.11
   After 24 hr (mg) 29.7 (19.0–40.3) 18.8 (10.2–27.4) 35.5 (28.4–42.6) 0.06
   After 24 hr per kg (mg/kg) 0.38 (0.26–0.50) 0.29 (0.15–0.42) 0.45 (0.36–0.53) 0.18
   After 48 hr (mg) 41.1 (25.0–57.1) 30.3 (14.9–45.6) 53.2 (41.6–64.9) 0.13
   After 48 hr per kg  (mg/kg) 0.40 (0.20–0.70) 0.47 (0.22–0.72) 0.70 (0.54–0.83) 0.25
Pain score 
   At 0 hr 1.3 (0.2–2.5) 1.7 (0.6–2.7) 2.5 (1.7–3.2) 0.24
   At 4 hr 1.2 (0.6–1.8) 1.3 (0.6–2) 1.5 (1.2–1.9) 0.65
   At 8 hr 1.8 (0.6–3.0) 0.9 (0.4–1.4) 1.2 (0.9–1.5) 0.2
   At 12 hr 2.4 (1.5–3.3) 2.1 (1–3.1) 2 (1.5–2.4) 0.72
   At 16 hr 1.4 (0.4–2.3) 1.9 (0.8–3) 1.6 (1.2–2) 0.72
   At 20 hr 1.7 (0.5–2.9) 2.1 (1.2–3.1) 2 (1.6–2.4) 0.8
   At 24 hr 1.3 (0.5–2.0) 2.3 (1–3.7) 1.8 (1.3–2.2) 0.28
   At 28 hr 1.4 (0.6–2.2) 1.7 (1–2.4) 1.7 (1.2–2.1) 0.83
   At 32 hr 1.7 (0.9–2.5) 1.4 (0.6–2.1) 1.8 (1.3–2.3) 0.65
   At 36 hr 1.3 (0.2–2.4) 1.0 (0–2.0) 1.6 (1.1–2.1) 0.57
   At 40 hr 2.0 (0.5–3.5) 2 (0.8–3.2) 1.7 (1.1–2.3) 0.87
   At 44 hr 1.9 (0.8–3.0) 2.7 (1.3–4.0) 1.6 (1.1–2.1) 0.16
   At 48 hr 1.1 (–0.1–2.3) 1.5 (–0.1–3.1) 1.2 (0.7–1.6) 0.85
Pain score at discharge 1.1 (0.3–1.8) 1.3 (0.3–2.3) 0.7 (0.4–1.0) 0.27
Maximum pain score 5.9 (4.7–7.0) 4.5 (3.5–5.6) 5.2 (4.7–5.7) 0.2
Time postoperative when maximum pain score 
experienced (hr)
14.9 (9.5–20.2) 14.3 (7.9–20.6) 13.4 (10.7–16.0) 0.88
Values are presented as mean (95% confidence interval).
DIEP, deep inferior epigastric artery perforator; PCA, patient-controlled analgesia.
a)Kruskal Wallis. Statistically significant, P<0.05.
Table 2. Twenty-five postoperative outcomes which were described and compared statistically across the three types of DIEP 
flap breast reconstruction (n=135)
Total morphine use Bipedicled, unilateral reconstruction (n=17)
Unipedicled, unilateral reconstruction 
(n=65) P-value
After 12 hr (mg) 6.8 (3.0–18.0) 17.5 (7.8–26.5) 0.005
After 12 hr per kg (mg/kg) 0.11 (0.06–0.28) 0.23 (0.11–0.36) 0.040
After 24 hr (mg) 11.0 (4.0–30.0) 29.0 (12.8–50.0) 0.020
After 24 hr per kg (mg/kg) 0.17 (0.06–0.50) 0.40 (0.18–0.61) 0.064
After 48 hr (mg) 14.0 (4.0–49.3) 43.8 (18.8–77.0) 0.046
After 48 hr per kg (mg/kg) 0.22 (0.06–0.80) 0.51 (0.24–0.96) 0.110
Values are presented as median (interquartile range).
DIEP, deep inferior epigastric artery perforator. 
a)Mann Whitney U test. Statistically significant, P<0.05. 
Table 3. Comparing patients’ total morphine requirements within the first 48 hours postoperatively: unilateral bipedicled 
compared to unilateral unipedicled DIEP reconstructions
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Pain scores: across all three groups then pairwise
Three-way comparison: there were no statistical differences 
(Kruskal Wallis tests) in patient pain scores between the three 
types of reconstruction at 4 hourly intervals in the first 48-hour 
postoperative period, including at 0 hour (i.e., immediately post-
operatively when the mean pain scores were 1.3, 1.7, and 2.5 for 
bilateral, unilateral bipedicled and unilateral unipedicled patients 
respectively). Similarly, there were no significant differences be-
tween the three procedure types for pain scores on discharge, nor 
between their maximum postoperative pain scores, time of maxi-
mum pain scores or the length of PCA use (Table 2). 
Pairwise comparisons: there were no statistically significant 
differences in 4-hourly pain scores in the first 48 hours between 
unilateral and bilateral reconstructions or between bipedicled 
and bilateral reconstructions when compared directly (Mann 
Whitney U test). 
Maximal pain scores
84% of patients reported their maximum pain scores in the first 
24 hours post-surgery and there was no difference in the maxi-
mum pain scores experienced dependent upon the three proce-
dure types (P = 0.24, Kruskal Wallis test) (Table 2). 
Other parameters
A high proportion of patients (61.0%) experienced postopera-
tive nausea or vomiting. There was no significant difference in 
proportions of those experiencing nausea and vomiting based 
on procedure type (P = 0.97; chi-square statistical test). Fur-
thermore, there seemed to be no relationship between the total 
morphine usage and whether the patient suffered from trouble-
some nausea and vomiting or not at the 12, 24 or 48-hour time-
points (P = 0.93, P = 0.69, P = 0.88, respectively; Mann Whitney 
U statistical test). 
Time to catheter removal, a proxy for ambulation post-proce-
dure, was not significantly different between the three groups 
(P = 0.26, Kruskal Wallis statistical test). However, mean length 
of hospital stay in the bilateral group was significantly longer at 
10.2 days compared to unilateral reconstructions (bipedi-
cled = 7.8 days, P < 0.001; unipedicled = 7.7 days, P < 0.001; 
Mann Whitney U statistical test).
DISCUSSION
This is the first study to examine a comprehensive set of mea-
sures of postoperative pain in DIEP reconstructions exclusively 
and to include a detailed analysis of the pain profile of the uni-
lateral bipedicled DIEP flap breast reconstructions [7-9]. Such 
data would be useful for patient counselling and serve to better 
inform us on optimising pain control. This also provides vital 
information to develop enhanced recovery programs with the 
goal to improve patient experience. In order to eliminate inter-
operator variability and the effect on pain perception caused by 
different flap recipient vessel sites, all the patients were operated 
on using a standardized, rib-sparing technique of internal mam-
mary recipient vessel exposure, with a standardized postopera-
tive protocol and by a single experienced microsurgeon. 
Parameter
Total morphine use after 
12 hr (mg)
Total morphine use after 
24 hr (mg)
Total morphine use after 
48 hr (mg)
Co-efficient P-value Co-efficient P-value Co-efficient P-value
Age at operation (yr) –0.18 0.34 0.51 0.086 –1.16 0.013
Body mass index (kg/m2) 0.02 0.95 0.12 0.84 –0.27 0.76
Timing of reconstruction Delayeda) –4.03 0.33 –10.10 0.12 –12.40 0.23
Immediate Reference Reference Reference
Smoking status Non-smokera) –12.10 0.049 –25.70 0.010 –38.47 0.01
Smoker Reference Reference Reference
Diabetic comorbidity Non-diabetica) 13.90 0.16 16.10 0.31 14.60 0.55
Diabetic Reference Reference Reference
Chemotherapy No chemotherapya) 4.61 0.34 13.90 0.07 25.50 0.03
Experienced chemotherapy Reference Reference Reference
Radiotherapy No radiotherapya) –5.13 0.21 –7.20 0.26 –5.39 0.59
Experienced radiotherapy Reference Reference Reference
Type of reconstruction Bipedicleda) –8.73 0.038 –10.50 0.11 –13.90 0.18
Unipedicled Reference Reference Reference
DIEP, deep inferior epigastric artery perforator. 
a)The co-efficient describing the effect of the binary parameters on the total morphine use. For example, for smoking status the co-efficient and P-values are listed in terms 
of the effect of being a “non-smoker.” Statistically significant, P<0.05. 
Table 4. Regression model of total morphine use for patients undergoing unilateral bipedicled (n=17) and unilateral 
unipedicled (n=65) DIEP reconstructions at different timepoints
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The published literature suggests that bilateral free flap breast 
reconstructions might lead to greater postoperative pain than 
unilateral procedures [7-9]. For example, in Gassman et al. se-
ries (n = 834), patients undergoing bilateral breast reconstruc-
tion with several different types of abdominal based autologous 
flaps had significantly greater early postoperative morphine re-
quirements and pain scores than unilateral reconstructions [8]. 
Similarly, Kulkarni et al. (n = 2,207) documented increased pa-
tient-reported measures of early postoperative pain for different 
forms of bilateral reconstructive breast surgery [7]. This is not 
surprising as bilateral flap harvest is more invasive and such sur-
gery involves operating on two breasts. There is little published 
data on postoperative pain and early recovery specifically for 
different forms of DIEP flap reconstruction and there is only 
one previous study comparing postoperative pain and the num-
ber of vascular pedicles in DIEP reconstruction; Uda et al. 
(n = 67) report a single, patient-reported global measure of post-
operative pain immediately after surgery and found that patients 
with bipedicled DIEP flap reconstruction had significantly more 
life-limiting pain than unipedicled patients [9]. This is in direct 
contrast to our findings that this cohort of patients experienced 
less pain and required less morphine postoperatively. 
In the present study, bipedicled reconstructions led to the use 
of significantly lower doses of total morphine after 12 hours 
postoperatively across the three procedure types after both uni-
variate and multivariable analyses. In addition, bipedicled recon-
structions required significantly lower doses of total morphine 
when compared to unilateral unipedicled reconstructions after 
12, 24, and 48 hours postoperatively using univariate analyses. 
Multivariable linear regression confirmed that bipedicled recon-
struction was still associated with lower postoperative morphine 
requirements at 12 hours. This remains an unexpected finding 
and is contrary to our expectations and the findings of others 
[9]. We would have anticipated that bipedicled unilateral recon-
struction patients should have more pain and higher morphine 
use due to two donor sites and often exposure of two intercostal 
spaces for the microanastomoses to the internal mammary ves-
sels. Additionally, these were slightly younger patients and the 
literature suggests that they may tend towards higher morphine 
use [7,10]. More work needs to be done in this regard possibly 
also examining intraoperative depth of sedation and analgesia to 
help to decipher this conundrum. 
Although, at 24 hours the difference observed on univariate 
analysis between bipedicled and unipedicled reconstructions 
was shown on multivariable analysis to be attributed to smoking 
status and at 48 hours to smoking status, younger age and prior 
chemotherapy. No other differences between patients undergo-
ing bipedicled unilateral, unipedicled unilateral and bilateral re-
constructions were observed in 21 other parameters (Table 2). 
Multivariable regression analysis highlighted that smoking, age 
and prior chemotherapy affect postoperative morphine require-
ments. Being a non-smoker reduced postoperative morphine 
requirements after 12, 24, and 48 hours when comparing the 
unipedicled and bipedicled patients in our cohort. Additionally, 
at 48 hours increasing age and prior chemotherapy significantly 
decreased morphine requirements. Being a smoker is a well de-
scribed cause of increased postoperative morphine use and this 
is likely due to nicotine’s chronic effects on the nicotinic acetyl-
choline receptor [11]. However, in our study this finding should 
be interpreted with caution due to the small patient numbers. 
Older age has been associated with lower postoperative mor-
phine requirements in various types of surgery [10]. In addition, 
younger age leading to higher pain scores have been observed in 
breast surgery, but not yet for morphine requirements [7]. An-
other novel finding from our study was that prior chemotherapy 
has not hitherto been reported to be associated with differences 
in postoperative morphine requirements or pain scores.
Our cohort’s total morphine requirements (mean ± standard 
deviation) were 31.6 ± 26.3 mg at 24 hours and 47.2 ± 43 mg at 
48 hours, which is comparable to or lower than similar datasets 
[12,13]. Zhong et al. [13] reported a 44 patient case series of 
predominately DIEP (68%) flap autologous breast reconstruc-
tions in which the total equivalent morphine use was 30.0 ± 19.1 
mg at 24 hours. This suggests that our figures are valid and the 
results likely to be applicable to similar patients in other centers.
As regards patient-reported pain scores, there is one compara-
ble data set. Parikh et al. [14] in a case series of 78 microvascular 
free flap transfers of abdominal autologous tissue report median 
(interquartile range, IQR) pain scores at 2 hours of 5 (IQR, 4–6) 
on the 11-point NRS and 4 (IQR, 3–5) at 24 hours; our whole 
cohort has median pain scores of 1 (IQR, 0–4) at 0 hour, 1 (IQR, 
0–2) at 4 hours and 1 (IQR, 0–3) at 24 hour on a 10 point NRS. 
This suggests that pain in our cohort was well controlled com-
pared to published literature. 
It was interesting that patients who did and did not experience 
postoperative nausea and vomiting did not use significantly dif-
ferent amounts of morphine postoperatively at the 12-, 24-, and 
48-hour time points; this makes it unlikely that morphine is the 
predominant factor causing nausea and vomiting. 
Bilateral reconstructions had statistically and clinically signifi-
cantly longer lengths of stay by 2.4 days (Table 2). This increase 
for bilateral procedures is well documented in the literature 
[15]. It is also expected as bilateral surgery is more invasive, lasts 
longer and is associated with a longer recovery in terms of mo-
bilization. However, our study suggests that this is not due to in-
creased pain at the donor sites or the need for greater morphine. 
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Our length of stay is however similar to representative UK co-
horts of DIEP and other autologous tissue-based breast recon-
structions which have reported mean length of stay ranging be-
tween 6.8 and 10.2 days [16-18]. Historically earlier discharges 
have been reported in North American studies with mean 
length of stay between 4 and 5 days [14,15,19,20].
Several limitations of this study are due to the retrospective 
study design. Firstly, it is important to stress that this study con-
tained relatively few participants and sample size which includ-
ed small numbers in key categories such as different times of re-
construction, diabetic patients and smokers. For example, there 
was ultimately only one patient in the bilateral group who 
smoked therefore the association with higher postoperative pain 
scores could have due to this single individual’s unusual require-
ments rather than a robust phenomenon. It would have been in-
formative to record a more complete evaluation of pain includ-
ing the background, mobilization and breakthrough elements, 
whether the PCA was effective for reducing their pain, the sys-
temic doses of intraoperative analgesics given and whether the 
patient took analgesics prior to admission because this could af-
fect their baseline analgesic requirements [7]. Finally, a more ro-
bust evaluation of nausea and vomiting would have been infor-
mative; we could find out with a careful prospective study when 
the nausea and vomiting occurred and if that was related to re-
cent morphine dosing. 
The development and adoption of enhanced recovery path-
ways is a new and expanding area [21]. In breast reconstruction, 
these evidence-based pathways could help to improve postoper-
ative morbidity, accelerate ambulation and perhaps discharge 
[21]. DIEP autologous flap breast reconstructions are associat-
ed with long operative and anaesthesia times, notable pain and 
morbidity [4]. Our study provides a baseline for us to quantify 
changes in opiate use and nausea and vomiting, for example if 
trialing regional blocks at the abdominal donor site, and in mo-
bilization and discharge after intraoperative surgical site anaes-
thesia, early urinary catheter removal and earlier mobilization 
[14,20-22]. In addition, this study highlights that it might be 
more difficult to control the pain of patients who have received 
unipedicled reconstructions, are smokers, younger and have not 
received prior neoadjuvant chemotherapy. Incorporating these 
observations into official enhanced recovery pathways or en-
hancing current postoperative protocols could improve patient 
experience, their recovery and morbidity [21]. Therefore, since 
this study, in collaboration with our anesthetic colleagues we 
have developed an enhanced recovery after surgery protocol in 
which our anesthetists routinely administer gabapentin along-
side PCA morphine to reduce morphine use, potentially nausea 
and vomiting and enable early ambulation. 
In conclusions, this is the first study to demonstrate that bi-
pedicled DIEP flap harvest might reduce early postoperative 
morphine requirements versus unipedicled procedures (wheth-
er patients are undergoing unilateral or bilateral breast recon-
structions). Interestingly however, across numerous parameters, 
in our study sample, all three forms of DIEP flap breast recon-
struction had similar measures of postoperative pain. Bilateral 
and bipedicled procedures in appropriate patients might there-
fore be undertaken without significantly increased pain/mor-
bidity compared to unilateral unipedicled reconstructions. Bilat-
eral free DIEP reconstruction, however, increase hospital stay 
and patients should be counselled appropriately.
NOTES
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